"This acquisition is part of Bilcare's overall business strategy to strengthen our footprint in the United States," Mohan Bhandari, chairman and CEO, Bilcare said.
"The transaction provides Bilcare entry into the world's largest pharmaceuticals market through an established organisation with an enviable roster of existing clients," he added.
ProClinical Inc is based in Phoenixville, US. Its client roster includes Johnson & Johnson, AstraZeneca, Bayer, Takeda and Merck and more than 100 biotech companies, US media reported.